They reported the high sensitivity (85%) and specificity (76%) of exosomal hnRNPH1 mRNA in discriminating HCC patients from chronic hepatitis B and suggested it could be utilised as a tool for cancer diagnosis [98]. This evidence concerns the gene HNRNPH1 and chronic hepatitis B virus infection.